ATE273957T1 - Bicyclische verbindungen als vitronectinrezeptorantagonisten, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zubereitungen - Google Patents
Bicyclische verbindungen als vitronectinrezeptorantagonisten, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zubereitungenInfo
- Publication number
- ATE273957T1 ATE273957T1 AT01969041T AT01969041T ATE273957T1 AT E273957 T1 ATE273957 T1 AT E273957T1 AT 01969041 T AT01969041 T AT 01969041T AT 01969041 T AT01969041 T AT 01969041T AT E273957 T1 ATE273957 T1 AT E273957T1
- Authority
- AT
- Austria
- Prior art keywords
- production
- receptor antagonists
- pharmaceutical preparations
- preparations containing
- containing same
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D223/12—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0002902A FR2806082B1 (fr) | 2000-03-07 | 2000-03-07 | Nouveaux composes bicycliques antagonistes des recepteurs de la vitronectine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
PCT/FR2001/000650 WO2001079172A1 (fr) | 2000-03-07 | 2001-03-06 | Composes bicycliques antagonistes des recepteurs de la vitronectine, leur procede de preparation et les compositions qui les contiennent |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE273957T1 true ATE273957T1 (de) | 2004-09-15 |
Family
ID=8847803
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01969041T ATE273957T1 (de) | 2000-03-07 | 2001-03-06 | Bicyclische verbindungen als vitronectinrezeptorantagonisten, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zubereitungen |
Country Status (27)
Country | Link |
---|---|
US (1) | US6846833B2 (de) |
EP (1) | EP1268429B1 (de) |
JP (1) | JP3974780B2 (de) |
KR (1) | KR100530523B1 (de) |
CN (1) | CN1216866C (de) |
AR (1) | AR029485A1 (de) |
AT (1) | ATE273957T1 (de) |
AU (2) | AU2001293374B2 (de) |
BR (1) | BR0108998A (de) |
CA (1) | CA2402686C (de) |
CZ (1) | CZ301808B6 (de) |
DE (1) | DE60105001T2 (de) |
DK (1) | DK1268429T3 (de) |
EA (1) | EA005155B1 (de) |
ES (1) | ES2227265T3 (de) |
FR (1) | FR2806082B1 (de) |
HK (1) | HK1052345B (de) |
HU (1) | HU229343B1 (de) |
MX (1) | MXPA02008633A (de) |
NO (1) | NO324052B1 (de) |
NZ (1) | NZ520805A (de) |
PL (1) | PL356886A1 (de) |
PT (1) | PT1268429E (de) |
SI (1) | SI1268429T1 (de) |
SK (1) | SK286882B6 (de) |
WO (1) | WO2001079172A1 (de) |
ZA (1) | ZA200206354B (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2806082B1 (fr) * | 2000-03-07 | 2002-05-17 | Adir | Nouveaux composes bicycliques antagonistes des recepteurs de la vitronectine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US9034910B2 (en) | 2008-06-09 | 2015-05-19 | Allergan, Inc. | Methods of treating alpha adrenergic mediated conditions |
ES2672777T3 (es) * | 2008-06-09 | 2018-06-18 | Allergan, Inc. | Métodos de tratamiento de estados con mediación alfa-adrenérgica |
KR102281647B1 (ko) | 2020-12-09 | 2021-07-30 | 메디케어제약 주식회사 | 피페라진-퀴놀린 유도체의 제조방법 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6403578B1 (en) * | 1993-12-21 | 2002-06-11 | Smithkline Beecham Corporation | Bicyclic fibrinogen antagonists |
JPH10504808A (ja) * | 1994-06-29 | 1998-05-12 | スミスクライン・ビーチャム・コーポレイション | ビトロネクチン受容体拮抗物質 |
US6008214A (en) * | 1994-08-22 | 1999-12-28 | Smithkline Beecham Corporation | Bicyclic compounds |
ES2171768T3 (es) * | 1996-03-20 | 2002-09-16 | Hoechst Ag | Inhibidores de la resorcion osea y antagonistas de receptores de vitronectina. |
UA60311C2 (uk) * | 1996-10-02 | 2003-10-15 | Смітклайн Бічам Корпорейшн | Антагоністи рецептора вітронектину, спосіб одержання цих сполук та фармацевтична композиція |
CO4920232A1 (es) * | 1997-01-08 | 2000-05-29 | Smithkline Beecham Corp | Acidos aceticos dibenzo [a,d] cicloheptano con actividad antagonista del receptor de vitronectin |
US6559144B2 (en) * | 1997-02-13 | 2003-05-06 | Merck Patent Gesellschaft Mit | Bicyclic amino acids |
WO1999005107A1 (en) * | 1997-07-25 | 1999-02-04 | Smithkline Beecham Corporation | Vitronectin receptor antagonist |
PE122699A1 (es) * | 1997-09-19 | 2000-02-12 | Smithkline Beecham Corp | Antagonistas de receptores de vitronectina |
US6524553B2 (en) * | 1998-03-31 | 2003-02-25 | Bristol-Myers Squibb Pharma Company | Quinolone vitronectin receptor antagonist pharmaceuticals |
EP0960882A1 (de) * | 1998-05-19 | 1999-12-01 | Hoechst Marion Roussel Deutschland GmbH | Thienyl substituiertre Acylguanidine und ihre Verwendung als Knochenresorptionhemmer und als Vitronectinrezeptor-Antagoniste |
FR2786182B1 (fr) * | 1998-11-24 | 2001-01-12 | Hoechst Marion Roussel Inc | Nouveaux derives d'acylguanidines, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant |
DE19916837A1 (de) * | 1999-04-14 | 2000-10-19 | Merck Patent Gmbh | Dibenzoazulenderivate |
US6514964B1 (en) * | 1999-09-27 | 2003-02-04 | Amgen Inc. | Fused cycloheptane and fused azacycloheptane compounds and their methods of use |
FR2806082B1 (fr) * | 2000-03-07 | 2002-05-17 | Adir | Nouveaux composes bicycliques antagonistes des recepteurs de la vitronectine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
2000
- 2000-03-07 FR FR0002902A patent/FR2806082B1/fr not_active Expired - Fee Related
-
2001
- 2001-03-06 PL PL01356886A patent/PL356886A1/xx not_active Application Discontinuation
- 2001-03-06 KR KR10-2002-7011689A patent/KR100530523B1/ko not_active IP Right Cessation
- 2001-03-06 ES ES01969041T patent/ES2227265T3/es not_active Expired - Lifetime
- 2001-03-06 CZ CZ20022992A patent/CZ301808B6/cs not_active IP Right Cessation
- 2001-03-06 US US10/220,755 patent/US6846833B2/en not_active Expired - Fee Related
- 2001-03-06 DE DE60105001T patent/DE60105001T2/de not_active Expired - Lifetime
- 2001-03-06 NZ NZ520805A patent/NZ520805A/xx not_active IP Right Cessation
- 2001-03-06 HU HU0300181A patent/HU229343B1/hu not_active IP Right Cessation
- 2001-03-06 EA EA200200878A patent/EA005155B1/ru not_active IP Right Cessation
- 2001-03-06 JP JP2001576773A patent/JP3974780B2/ja not_active Expired - Fee Related
- 2001-03-06 PT PT01969041T patent/PT1268429E/pt unknown
- 2001-03-06 WO PCT/FR2001/000650 patent/WO2001079172A1/fr active IP Right Grant
- 2001-03-06 SI SI200130167T patent/SI1268429T1/xx unknown
- 2001-03-06 AT AT01969041T patent/ATE273957T1/de active
- 2001-03-06 CN CN018060986A patent/CN1216866C/zh not_active Expired - Fee Related
- 2001-03-06 AU AU2001293374A patent/AU2001293374B2/en not_active Ceased
- 2001-03-06 DK DK01969041T patent/DK1268429T3/da active
- 2001-03-06 MX MXPA02008633A patent/MXPA02008633A/es active IP Right Grant
- 2001-03-06 CA CA002402686A patent/CA2402686C/fr not_active Expired - Fee Related
- 2001-03-06 EP EP01969041A patent/EP1268429B1/de not_active Expired - Lifetime
- 2001-03-06 SK SK1270-2002A patent/SK286882B6/sk not_active IP Right Cessation
- 2001-03-06 AU AU9337401A patent/AU9337401A/xx active Pending
- 2001-03-06 BR BR0108998-6A patent/BR0108998A/pt not_active IP Right Cessation
- 2001-03-07 AR ARP010101058A patent/AR029485A1/es not_active Application Discontinuation
-
2002
- 2002-08-08 ZA ZA200206354A patent/ZA200206354B/en unknown
- 2002-09-06 NO NO20024275A patent/NO324052B1/no not_active IP Right Cessation
-
2003
- 2003-06-24 HK HK03104528.0A patent/HK1052345B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE50113328D1 (de) | Bicyclische heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung | |
DE50111799D1 (de) | Bicyclische heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung | |
DE60022866D1 (de) | Bizyklische heterozyklen, diese verbindungen enthaltende zusammenstellungen und verfahren zu deren herstellung | |
ATE296823T1 (de) | Substituierte heterocyclische verbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen | |
ATE252562T1 (de) | Pyrazolcarbonsäurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
DE60215851D1 (de) | N-adamantylmethyl-derivate und zwischenprodukte als pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung | |
DE69811735T2 (de) | Heterocyclische verbindungen zur hemmung der magensäureproduktion, verfahren zu ihrer herstellung und pharmazeutische zubereitungen davon | |
ATE430136T1 (de) | Chinazolinderivate, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung | |
DE50207522D1 (de) | Neue dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel | |
DE50111293D1 (de) | Diphenylazetidinonderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung | |
DE50110906D1 (de) | Diphenylazetidinonderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung | |
ATE215951T1 (de) | Tetracyclische campothecineanalogue, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zubereitungen | |
DE59707503D1 (de) | Neue arylglycinamidderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen | |
DE69909209D1 (de) | Pyrimidinon-derivate, diese verbindungen enthaltenden pharmazeutische zubereitungen und verfharen zu ihrer herstellung | |
DE60301570D1 (de) | 1,2,3-substituierte indolizinderivate, fgf inhibitoren, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
ATE323092T1 (de) | Pyridopyrimidinon-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
DE60318167D1 (de) | Arzneiform und Verfahren zu ihrer Herstellung | |
ATE294175T1 (de) | 4-sulfonamid-piperidin-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen | |
ATE544448T1 (de) | Morphinsulfat enthaltende mikrogranulate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen | |
DE60010113D1 (de) | N-guanidinalkylamide, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische präparate | |
ATE222586T1 (de) | Benzolsulfonamidderivate und verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
ATE244246T1 (de) | Pyridothienodiazepine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
ATE273957T1 (de) | Bicyclische verbindungen als vitronectinrezeptorantagonisten, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
ATE254124T1 (de) | Octahydro-2h-pyrido(1,2-a)pyrazinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
DE502004007916D1 (de) | Amidomethyl-substituierte 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro- 2h-chromen-6-yl-derivate, verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1268429 Country of ref document: EP |